Dongkook Pharmaceutical Co Ltd banner

Wall St Price Targets

Price Forecast
Based on 6 analysts

+29% Upside
from ₩23 650 today

Dongkook Pharmaceutical Co Ltd (086450)’s 12-month stock price forecast through November 2027 has a consensus target of ₩30 600, implying 29% upside. The forecast is based on price targets from 6 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Dongkook Pharmaceutical Co Ltd yet.

Dongkook Pharmaceutical Co Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Dongkook Pharmaceutical Co Ltd's stock price target?
Price Target
30 600 KRW

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 30 600 KRW with a low forecast of 29 290 KRW and a high forecast of 33 600 KRW.

What is the Revenue forecast for Dongkook Pharmaceutical Co Ltd?
Projected CAGR
13%

Over the last 12 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 13%.

What is the Gross Profit forecast for Dongkook Pharmaceutical Co Ltd?
Projected CAGR
13%

Over the last 12 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 13%.

What is the Operating Income forecast for Dongkook Pharmaceutical Co Ltd?
Projected CAGR
15%

Over the last 12 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 15%.

What is the Pre-Tax Income forecast for Dongkook Pharmaceutical Co Ltd?
Projected CAGR
17%

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 17%.

What is the Net Income forecast for Dongkook Pharmaceutical Co Ltd?
Projected CAGR
20%

Over the last 12 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 20%.

Back to Top